首页> 外国专利> Method and use of protein microarray technology and proteomic analysis to determine efficacy of human and xenographic cell, tissue and organ transplant

Method and use of protein microarray technology and proteomic analysis to determine efficacy of human and xenographic cell, tissue and organ transplant

机译:蛋白质微阵列技术和蛋白质组学分析确定人类和异种细胞,组织和器官移植的功效的方法和用途

摘要

The present invention is directed to systems and methods for assessing the success of the transplant of a cell, tissue, or organ before and after transplant. Protein array technology is used to obtain a biomarker pattern for the cell, tissue, or organ that is being considered for transplant or that has been transplanted. Samples for the identification of biomarkers and biomarker patterns are obtained from the cell, tissue or organ itself, or from a body fluid of the donor or recipient. Sample biomarker data are compared to reference biomarker data obtained from donors, recipients or cells, tissues or organs that have been transplanted. Correlation of a sample biomarker pattern with the reference biomarker pattern, where transplant outcome for the samples used for the reference biomarkers is known, permits a suggested treatment determination. A computerized system to identify the condition of transplant before or after implantation is also provided.
机译:本发明涉及在移植之前和之后评估细胞,组织或器官移植成功与否的系统和方法。蛋白质阵列技术用于获得正在考虑移植或已经移植的细胞,组织或器官的生物标记模式。用于鉴定生物标志物和生物标志物图案的样品是从细胞,组织或器官本身,或从供体或受体的体液中获得的。将样品生物标志物数据与从已移植的供体,受体或细胞,组织或器官中获得的参考生物标志物数据进行比较。样品生物标志物图案与参考生物标志物图案的相关性(其中已知用于参考生物标志物的样品的移植结果是已知的)允许建议的治疗确定。还提供了在植入之前或之后识别移植状况的计算机系统。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号